• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.

作者信息

Chiricozzi Andrea, Balato Anna, Fabbrocini Gabriella, Di Nardo Lucia, Babino Graziella, Rossi Mariateresa, Esposito Maria, Bertoldi Alberto Maria, Girolomoni Giampiero, Gambardella Alessio, Antonelli Flaminia, Patruno Cataldo, Fargnoli Maria Concetta, Argenziano Giuseppe, Peris Ketty

机构信息

Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.

Dermatology Unit, University of Campania Luigi Vanvitelli Naples, Naples, Italy.

出版信息

J Am Acad Dermatol. 2023 Dec;89(6):1251-1253. doi: 10.1016/j.jaad.2023.05.001. Epub 2023 May 9.

DOI:10.1016/j.jaad.2023.05.001
PMID:37169293
Abstract
摘要

相似文献

1
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.乌帕替尼对特应性皮炎相关斑秃的有益作用：一项多中心回顾性研究。
J Am Acad Dermatol. 2023 Dec;89(6):1251-1253. doi: 10.1016/j.jaad.2023.05.001. Epub 2023 May 9.
2
Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib.乌帕替尼成功治疗同时患有慢性斑秃和重度特应性皮炎的患者
Int J Dermatol. 2022 Nov;61(11):e416-e417. doi: 10.1111/ijd.16316. Epub 2022 Jun 20.
3
Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata.乌帕替尼对2例同时患有重度特应性皮炎和斑秃患者的双重疗效
Dermatitis. 2021 Oct 1;32(1S):e85-e86. doi: 10.1097/DER.0000000000000780.
4
Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report.乌帕替尼改善了一名特应性皮炎患者的斑秃：病例报告。
Dermatol Ther. 2022 Apr;35(4):e15346. doi: 10.1111/dth.15346. Epub 2022 Feb 10.
5
Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.达必妥治疗中重度特应性皮炎伴斑秃患者 1 例并文献复习
Australas J Dermatol. 2020 May;61(2):e223-e225. doi: 10.1111/ajd.13208. Epub 2019 Nov 25.
6
Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata.使用乌帕替尼选择性抑制JAK 1作为同时存在的重度特应性皮炎和斑秃的潜在治疗方法。
An Bras Dermatol. 2024 May-Jun;99(3):483-484. doi: 10.1016/j.abd.2023.07.003. Epub 2024 Feb 24.
7
Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report.度普利尤单抗改善了一名特应性皮炎患者的斑秃：病例报告
Acta Derm Venereol. 2019 Jun 1;99(7):675-676. doi: 10.2340/00015555-3183.
8
Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients.度普利尤单抗对两名患者的特应性皮炎和斑秃的同时有效性。
J Dtsch Dermatol Ges. 2019 Dec;17(12):1278-1280. doi: 10.1111/ddg.13990. Epub 2019 Dec 12.
9
Improvement of severe alopecia areata after 9-month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis.一名特应性皮炎患者在接受9个月的巴瑞替尼治疗后严重斑秃得到改善，随后使用乌帕替尼。
J Dermatol. 2023 Nov;50(11):e392-e393. doi: 10.1111/1346-8138.16893. Epub 2023 Jul 23.
10
Interleukin-13 as a promising therapeutic target for alopecia areata associated with atopic dermatitis.
Int J Dermatol. 2024 Mar;63(3):268-269. doi: 10.1111/ijd.17053. Epub 2024 Jan 29.

引用本文的文献

1
Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review.评估斑秃的现有和新型JAK抑制剂：一项叙述性综述
Dermatol Ther (Heidelb). 2025 Aug 12. doi: 10.1007/s13555-025-01517-9.
2
20 years of the socioeconomic impact of atopic dermatitis and alopecia areata from around the globe.全球范围内特应性皮炎和斑秃的社会经济影响20年研究
Clin Transl Allergy. 2025 May;15(5):e70061. doi: 10.1002/clt2.70061.
3
Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata-A Small Retrospective Cohort Study.
双重缓解：特应性皮炎治疗如何影响斑秃——一项小型回顾性队列研究
Diagnostics (Basel). 2025 Feb 20;15(5):520. doi: 10.3390/diagnostics15050520.
4
Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata.斑秃对 JAK 抑制剂反应不足的预测因素和管理。
Am J Clin Dermatol. 2024 Nov;25(6):975-986. doi: 10.1007/s40257-024-00884-x. Epub 2024 Sep 3.
5
Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib.病例报告：用乌帕替尼治疗伴有免疫介导合并症的类银屑病样湿疹。
Front Immunol. 2024 Aug 5;15:1432233. doi: 10.3389/fimmu.2024.1432233. eCollection 2024.
6
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.合并症和特殊人群的中重度特应性皮炎患者的生物制剂和小分子治疗：意大利视角
Dermatol Reports. 2023 Sep 13;16(2):9839. doi: 10.4081/dr.2023.9839. eCollection 2024 Jun 14.
7
Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient.乌帕替尼成功治疗一名29岁男性患者的重度特应性皮炎和普秃。
J Allergy Clin Immunol Glob. 2024 May 1;3(3):100269. doi: 10.1016/j.jacig.2024.100269. eCollection 2024 Aug.
8
Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety.托法替布和巴瑞替尼在希腊斑秃患者中的真实世界用药经验：一项聚焦安全性的回顾性分析
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024073. doi: 10.5826/dpc.1402a73.
9
Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series.乌帕替尼用于不同背景下斑秃的病例系列研究
Clin Cosmet Investig Dermatol. 2024 Mar 9;17:565-571. doi: 10.2147/CCID.S458592. eCollection 2024.
10
Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata.使用乌帕替尼选择性抑制JAK 1作为同时存在的重度特应性皮炎和斑秃的潜在治疗方法。
An Bras Dermatol. 2024 May-Jun;99(3):483-484. doi: 10.1016/j.abd.2023.07.003. Epub 2024 Feb 24.